BiomX Inc. (PHGE) is priced at $2.59 after the most recent trading session. At the very opening of the session, the stock price was $2.75 and reached a high price of $2.75, prior to closing the session it reached the value of $2.73. The stock touched a low price of $2.48.Recently in News on October 13, 2021, BiomX Announces Agreement with Maruho Co., Ltd. for Atopic Dermatitis Product Candidate BX005. BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing novel natural and engineered phage cocktails that target specific pathogenic bacteria, announced today that it has entered into an agreement granting Maruho Co. Ltd., a leading dermatology-focused pharmaceutical company in Japan, a right of first offer to license BiomX’s atopic dermatitis product candidate, BX005, in Japan. The right of first offer will commence following the availability of results from the Phase 1/2 study of BX005 expected in 2022. Maruho also entered into a binding agreement for an equity investment in BiomX of $3 million at a premium to the market share price, intended primarily to support the Phase 1/2 study. You can read further details here
BiomX Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $9.05 on 02/22/21, with the lowest value was $2.48 for the same time period, recorded on 10/13/21.
BiomX Inc. (PHGE) full year performance was -58.03%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, BiomX Inc. shares are logging -71.39% during the 52-week period from high price, and -2.65% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.66 and $9.05.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 838196 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the BiomX Inc. (PHGE) recorded performance in the market was -59.41%, having the revenues showcasing -48.21% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 72.97M, as it employees total of 95 workers.
The Analysts eye on BiomX Inc. (PHGE)
During the last month, 0 analysts gave the BiomX Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 4.43, with a change in the price was noted -3.50. In a similar fashion, BiomX Inc. posted a movement of -57.48% for the period of last 100 days, recording 53,325 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for PHGE is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of BiomX Inc. (PHGE)
Raw Stochastic average of BiomX Inc. in the period of last 50 days is set at 5.64%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 11.36%. In the last 20 days, the company’s Stochastic %K was 9.41% and its Stochastic %D was recorded 9.77%.
Considering, the past performance of BiomX Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -59.41%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -61.58%, alongside a downfall of -58.03% for the period of the last 12 months. The shares increased approximately by -5.15% in the 7-day charts and went up by -18.57% in the period of the last 30 days. Common stock shares were lifted by -48.21% during last recorded quarter.